PortfoliosLab logoPortfoliosLab logo
AMPH vs. MSFT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMPH vs. MSFT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amphastar Pharmaceuticals, Inc. (AMPH) and Microsoft Corporation (MSFT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMPH achieves a -24.98% return, which is significantly lower than MSFT's -18.85% return. Over the past 10 years, AMPH has underperformed MSFT with an annualized return of 2.48%, while MSFT has yielded a comparatively higher 24.39% annualized return.


AMPH

1D
-2.14%
1M
16.13%
YTD
-24.98%
6M
-20.50%
1Y
-22.19%
3Y*
-24.72%
5Y*
0.17%
10Y*
2.48%

MSFT

1D
0.10%
1M
-4.36%
YTD
-18.85%
6M
-17.98%
1Y
-17.07%
3Y*
6.16%
5Y*
9.56%
10Y*
24.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMPH vs. MSFT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AMPH
Amphastar Pharmaceuticals, Inc.
-24.98%-27.88%-39.97%120.74%20.31%15.81%4.25%-3.07%3.43%4.45%
MSFT
Microsoft Corporation
-18.85%15.58%12.93%58.19%-28.02%52.48%42.53%57.56%20.80%40.73%

Correlation

The correlation between AMPH and MSFT is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jun 25, 2014

0.21

The correlation between AMPH and MSFT shifts across timeframes, from 0.06 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AMPH:

$933.34M

MSFT:

$2.91T

EPS

AMPH:

$1.67

MSFT:

$16.79

PE Ratio

AMPH:

12.01

MSFT:

23.27

PEG Ratio

AMPH:

0.64

MSFT:

1.63

PS Ratio

AMPH:

1.32

MSFT:

9.16

PB Ratio

AMPH:

1.21

MSFT:

7.02

Total Revenue (TTM)

AMPH:

$720.53M

MSFT:

$318.27B

Gross Profit (TTM)

AMPH:

$341.13M

MSFT:

$217.41B

EBITDA (TTM)

AMPH:

$155.96M

MSFT:

$200.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMPH vs. MSFT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMPH
AMPH Risk / Return Rank: 2323
Overall Rank
AMPH Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
AMPH Sortino Ratio Rank: 2525
Sortino Ratio Rank
AMPH Omega Ratio Rank: 2424
Omega Ratio Rank
AMPH Calmar Ratio Rank: 2424
Calmar Ratio Rank
AMPH Martin Ratio Rank: 2020
Martin Ratio Rank

MSFT
MSFT Risk / Return Rank: 1717
Overall Rank
MSFT Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
MSFT Sortino Ratio Rank: 1515
Sortino Ratio Rank
MSFT Omega Ratio Rank: 1414
Omega Ratio Rank
MSFT Calmar Ratio Rank: 2424
Calmar Ratio Rank
MSFT Martin Ratio Rank: 2020
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMPH vs. MSFT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Microsoft Corporation (MSFT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMPHMSFTDifference
Sharpe ratioReturn per unit of total volatility

+0.25

Sortino ratioReturn per unit of downside risk

+0.54

Omega ratioGain probability vs. loss probability

0.95

0.89

+0.06

Calmar ratioReturn relative to maximum drawdown

-0.53

-0.53

-0.01

Martin ratioReturn relative to average drawdown

-1.07

-1.08

+0.01

AMPH vs. MSFT - Sharpe Ratio Comparison

The current AMPH Sharpe Ratio is -0.45, which is higher than the MSFT Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of AMPH and MSFT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMPH vs. MSFT - Drawdown Comparison

The maximum AMPH drawdown since its inception was -74.05%, which is greater than MSFT's maximum drawdown of -69.38%. Use the drawdown chart below to compare losses from any high point for AMPH and MSFT.


Loading charts...

Drawdown Indicators


AMPHMSFTDifference

Max Drawdown

Largest peak-to-trough decline

-74.05%

-69.38%

-4.67%

Max Drawdown (1Y)

Largest decline over 1 year

-45.25%

-33.91%

-11.34%

Max Drawdown (3Y)

Largest decline over 3 years

-74.05%

-33.91%

-40.14%

Max Drawdown (5Y)

Largest decline over 5 years

-74.05%

-37.15%

-36.90%

Max Drawdown (10Y)

Largest decline over 10 years

-74.05%

-37.15%

-36.90%

Current Drawdown

Current decline from peak

-69.09%

-27.46%

-41.63%

Average Drawdown

Average peak-to-trough decline

-24.08%

-21.78%

-2.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.54%

16.48%

+6.06%

Volatility

AMPH vs. MSFT - Volatility Comparison

Amphastar Pharmaceuticals, Inc. (AMPH) has a higher volatility of 12.20% compared to Microsoft Corporation (MSFT) at 10.52%. This indicates that AMPH's price experiences larger fluctuations and is considered to be riskier than MSFT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMPHMSFTDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.20%

10.52%

+1.68%

Volatility (6M)

Calculated over the trailing 6-month period

46.17%

22.31%

+23.86%

Volatility (1Y)

Calculated over the trailing 1-year period

53.78%

25.42%

+28.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.07%

26.66%

+18.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.71%

27.06%

+15.65%

Dividends

AMPH vs. MSFT - Dividend Comparison

AMPH has not paid dividends to shareholders, while MSFT's dividend yield for the trailing twelve months is around 0.91%.


PositionTTM20252024202320222021202020192018201720162015
AMPH
Amphastar Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MSFT
Microsoft Corporation
0.91%0.70%0.73%0.74%1.06%0.68%0.94%1.20%1.69%1.86%2.37%2.33%

Financials

AMPH vs. MSFT - Financials Comparison

This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Microsoft Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
171.17M
82.89B
(AMPH) Total Revenue
(MSFT) Total Revenue
Values in USD except per share items

AMPH vs. MSFT - Profitability Comparison

The chart below illustrates the profitability comparison between Amphastar Pharmaceuticals, Inc. and Microsoft Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%45.0%50.0%55.0%60.0%65.0%70.0%75.0%20222023202420252026
41.1%
67.6%
Portfolio components
AMPH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a gross profit of 70.32M and revenue of 171.17M. Therefore, the gross margin over that period was 41.1%.

MSFT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported a gross profit of 56.06B and revenue of 82.89B. Therefore, the gross margin over that period was 67.6%.

AMPH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported an operating income of 13.63M and revenue of 171.17M, resulting in an operating margin of 8.0%.

MSFT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported an operating income of 38.40B and revenue of 82.89B, resulting in an operating margin of 46.3%.

AMPH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a net income of 6.42M and revenue of 171.17M, resulting in a net margin of 3.8%.

MSFT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Microsoft Corporation reported a net income of 31.78B and revenue of 82.89B, resulting in a net margin of 38.3%.


Frequently Asked Questions


AMPH and MSFT have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMPH has higher volatility (12.20%) compared to MSFT (10.52%). In terms of maximum drawdown, AMPH dropped -74.05% vs MSFT's -69.38%.

AMPH currently has the higher Sharpe Ratio (-0.45 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMPH and MSFT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer